Long-Term Respiratory Muscle Endurance Training in Patients with Myasthenia Gravis: First Results after Four Months of Training
Table 2
Lung function data.
Patient
VC (L)
FEV1 (L)
PEF (L s−1)
MVV (L min−1)
(kPa)
B
P1
P4
B
P1
P4
B
P1
P4
B
P1
P4
B
P1
P4
1
3.8
4.1
4.2
3.1
3.3
3.9
7.1
6.2
7.6
142
150
133
9.1
9.4
9.5
2
3.9
3.8
4.0
3.1
3.1
3.1
8.6
8.0
8.4
138
131
188
9.5
10.9
11.4
3
3.1
3.4
3.3
2.3
2.6
2.4
4.5
5.1
4.7
74
73
84
5.6
6.9
7.0
4
3.7
3.7
3.6
2.9
3.2
2.9
7.6
9.4
9.0
130
152
144
8.9
8.9
8.3
5
3.7
3.4
3.5
2.8
2.5
2.5
7.7
7.8
8.9
124
121
114
4.3
5.3
5.3
6
3.9
3.6
4.4
2.7
2.6
3.5
4.7
5.3
7.2
73
89
105
6.6
5.8
6.3
7
2.8
2.7
2.6
2.1
2.1
2.0
4.9
5.1
4.4
91
91
97
5.6
6.6
5.1
8
4.6
4.7
4.4
3.1
2.9
2.9
7.0
7.4
7.4
162
154
155
8.1
9.0
9.3
9
2.6
2.6
2.8
2.1
2.4
2.3
4.6
4.4
5.1
76
75
81
5.9
5.1
4.6
10
2.7
2.9
3.5
1.9
2.2
2.5
7.1
7.6
7.5
94
92
90
5.9
5.8
6.1
Mean
3.5
3.5
3.6
2.6
2.7
2.8
6.4
6.6
7.0
110
113
119
6.7
7.1
7.1
SEM
0.20
0.20
0.20
0.15
0.13
0.18
0.49
0.52
0.53
10.3
10.3
11.1
0.57
0.67
0.75
VC; vital capacity; FEV1; forced expiratory volume in 1 s; PEF; peak expiratory flow; MVV; maximal voluntary ventilation; ; maximal inspiratory pressure. B; baseline values; P1; posttraining test after 4 weeks of training (phase 1); P4; posttraining test after 4 months of training (phase 2).
